ProfileGDS4718 / 225239_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 98% 97% 93% 98% 98% 96% 97% 94% 97% 98% 96% 98% 87% 97% 95% 98% 94% 96% 95% 96% 96% 92% 93% 98% 98% 94% 98% 98% 98% 95% 93% 92% 98% 97% 97% 92% 93% 97% 92% 87% 93% 99% 97% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.75398
GSM549102patient 115, normal, homogenized [OPG study]10.904397
GSM549104patient 119, normal, homogenized [OPG study]9.8960493
GSM549108patient 138, normal, homogenized [OPG study]11.344398
GSM549119patient 077, normal, homogenized [OPG study]11.419898
GSM549133patient 032, cancer, homogenized [OPG study]10.467896
GSM549139patient 042, cancer, homogenized [OPG study]10.667297
GSM549099patient 107, normal, homogenized [OPG study]9.9669694
GSM549109patient 139, normal, homogenized [OPG study]10.885697
GSM549110patient 046, normal, homogenized [OPG study]11.43198
GSM549114patient 063, normal, homogenized [OPG study]10.940696
GSM549122patient 082, normal, homogenized [OPG study]11.734598
GSM549134patient 033, cancer, homogenized [OPG study]8.7218187
GSM549136patient 036, cancer, homogenized [OPG study]10.761897
GSM549140patient 044, cancer, homogenized [OPG study]10.23395
GSM549111patient 047, normal, homogenized [OPG study]11.416998
GSM549113patient 057, normal, homogenized [OPG study]10.217794
GSM549132patient 031, cancer, homogenized [OPG study]10.358696
GSM549137patient 038, cancer, homogenized [OPG study]10.195995
GSM549142patient 047, cancer, homogenized [OPG study]10.141896
GSM549100patient 110, normal, homogenized [OPG study]10.556796
GSM549107patient 135, normal, homogenized [OPG study]9.6983292
GSM549115patient 068, normal, homogenized [OPG study]9.9821793
GSM549116patient 072, normal, homogenized [OPG study]11.516198
GSM549120patient 078, normal, homogenized [OPG study]11.748398
GSM549131patient 030, cancer, homogenized [OPG study]9.8976394
GSM549118patient 074, normal, homogenized [OPG study]11.339698
GSM549129patient 027, cancer, homogenized [OPG study]10.96698
GSM549123patient 088, normal, homogenized [OPG study]11.612998
GSM549124patient 006, cancer, homogenized [OPG study]10.029995
GSM549126patient 015, cancer, homogenized [OPG study]9.6782893
GSM549128patient 025, cancer, homogenized [OPG study]9.6001992
GSM549103patient 117, normal, homogenized [OPG study]11.456698
GSM549117patient 073, normal, homogenized [OPG study]11.167597
GSM549138patient 041, cancer, homogenized [OPG study]10.892797
GSM549141patient 045, cancer, homogenized [OPG study]9.5588392
GSM549130patient 028, cancer, homogenized [OPG study]9.6235593
GSM549101patient 111, normal, homogenized [OPG study]10.89397
GSM549105patient 128, normal, homogenized [OPG study]9.5580292
GSM549106patient 134, normal, homogenized [OPG study]8.9227387
GSM549112patient 048, normal, homogenized [OPG study]9.9351693
GSM549125patient 011, cancer, homogenized [OPG study]11.800399
GSM549127patient 024, cancer, homogenized [OPG study]10.898197
GSM549135patient 035, cancer, homogenized [OPG study]9.3763991